• News


MAY 2015, Horizon 2020-SME-Instrument-Phase 2

European Commission, within the frames of Horizon 2020-SME-Instrument-Phase 2 (PHC-12), has positively evaluated the project "GLIOMARK" and approved funding of €4.7 million for the next 4 years.

This is the only project related to nuclear medicine diagnostics and one of the few that were approved for funding  under the call: “PHC-12-2014 - Clinical research for the validation of biomarkers and/or diagnostic medical devices” (H2020-SMEINST-2-2014)

Contact us

Address:20, Delfon Street
151 25 Marousi,
Email:This email address is being protected from spambots. You need JavaScript enabled to view it.